Meningioma 1 antibody
Quick Overview for Meningioma 1 antibody (ABIN7116478)
Target
See all Meningioma 1 (MN1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- MN1 antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- meningioma(disrupted in balanced translocation) 1
-
Isotype
- IgG
-
-
-
-
Application Notes
- IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Alternative Name
- MN1
-
Background
-
Synonyms: Transcriptional activator MN1|Probable tumor suppressor protein MN1|MN1
Background: Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull(By similarity). May play a role in tumor suppression(Probable).
-
Gene ID
- 4330
-
UniProt
- Q10571
Target
-